ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 32 of 68
УЖМБС 2021, 6(5): 226–232
Clinical Medicine

Instrumental Impedance Measurement as a Component of an Objective Structured Clinical Examination to Determine Body Composition in Patients with Non-Communicable Diseases

Potiazhenko М. М. 1, Mintser О. P. 2, Nevoit G. V. 1

The purpose of the study is to assess the clinical feasibility and indicators of instrumental impedance measurement in patients who are at various stages of the cardiovascular continuum, in order to increase the effectiveness of measures for the prevention and treatment of non-communicable diseases in Ukraine by improving the diagnosis and prevention of non-communicable diseases through the introduction of modern science-intensive technologies into medical practice. Materials and methods. An open, non-randomized controlled study was performed with the assessment of examination on a BF 500 body composition monitor (model HBF-500-E, Omron Healthcare, Japan) in 186 functionally healthy individuals (control; in 75 respondents of professional athletes (group K1), in 111 respondents – intern doctors (group K2)) and in 253 patients with non-communicable diseases (main group). The patients were divided into four subgroups (Pg1, Pg2, Pg3, Pg4) depending on the stage of the cardiovascular continuum. Results and discussion. Non-compliance with the norm of body composition was found in 83% of respondents in group K2 and in 100% of patients. 83% of people were deficient in muscle, 23% had preobesity, 6% were obese, and 5% had visceral obesity. Overweight by body mass index was in 30% of Pg1 patients, in 31% of Pg2 patients, in 30% of Pg3 patients, in 37% of Pg4 patients and obesity was in 32% of Pg1 patients, in 31% of Pg2 patients, in 25% of Pg3 patients, in 35% of Pg4 patients. Overweight in the percentage of fat was diagnosed in 17% of Pg1 patients, in 31% of Pg2 patients, in 21% of Pg3 patients, in 37% of Pg4 patients; obesity was in 37% of Pg1 patients, in 48% of Pg2 patients, in 56% of Pg3 patients, in 51% of Pg4 patients. Visceral obesity was diagnosed in 35% of Pg1 patients, in 56% of Pg2 patients, in 60% of Pg3 patients, in 77% of Pg4 patients. Deficiency of muscle percentage was found in 85% of Pg1 patients, in 91% of Pg2 patients, in 89% of Pg3 patients, and in 88% of Pg4 patients. Conclusion. Instrumental impedance measurement shows clinical significance and should become a mandatory method of Objective Structured Clinical Examination. The body composition of patients with non-communicable diseases is characterized by an increase in energy expenditure of the main metabolism, general and visceral obesity, muscle deficiency. The degree and number of cases of violation of body composition increases with the progression of the cardiovascular continuum

Keywords: impedance measurement, non-communicable diseases, Objective Structured Clinical Examination

Full text: PDF (Ukr) 281K

  1. WHO. Noncommunicable diseases. 2021. Available from:
  2. Рotyazhenko MM, Nevoіt АV. Neynfektsyonnye zabolevanyya: poysk alternatyvnykh reshenyy problemy s byofyzycheskykh pozytsyy [Non-infectious diseases: search for alternative solutions to biophysical positions]. Praktykuyuchiy likar. 2019;1:57-62. [Russian]
  3. Kruglyy stil Verkhovnoyi Rady na temu «Peremogty smert: klyuchovi chynnyky, shcho vplyvayut na tryvalist zhyttya ukrayintsiv» vid 10 chervnya 2019 roku. [Round Table of the Verkhovna Rada on the topic "Defeat death: key factors influencing the life expectancy of Ukrainians" of 10 June 2019]. 2019. [Ukrainian]. Available from:
  4. Nevoіt GV. Otsinka klinichnoyi efektyvnosti sposobu vyznachennya personifikovanoyi korektsiyi stylyu zhyttya patsiyentiv ta novi perspektyvni predyktory neinfektsiynykh zakhvoryuvan [Evaluation of clinical efficiency of a method for determining personalized lifestyle correction of patients and new promising predictors of non-infectious diseases]. Ukr Terapevt Zh. 2021; 1: 20-25. [Ukrainian].
  5. Mintser OP, Semenets VV, Potiazhenko MМ, Рodpruzhnykov PМ. The study of the electromagnetic component of the human body as a diagnostic indicator in the examination of patients with Non-communicablediseases: problem statement. Wiad Lek. 2020;6(73):1279-1283.
  6. Popovych VI. Medytsyna «4R» yak osnova novoyi systemy okhorony zdorov’ya [Medicine "4P" as the basis of a new health system]. 2021. [Ukrainian]. Available from:
  7. Nevoit GV, Potiazhenko ММ, Mintser ОP, Ignatenko NI, Kаbernik YuА. Bioelectrical impedance determining body composition and hardware-software recording of heart rate variability during an Objective Structured Clinical Examination as a diagnostic tool. World Med Biol. 2020 2:89-93.
  8. Drapkyna OM, Kupreyshvyly LV, Fomyn VV. Kompozytsyonnyy sostav tela y ego rol v razvytyy metabolycheskykh narushenyy y serdechno-sosudystykh zabolevanyy [Composite composition of the body and its role in the development of metabolic disorders and cardiovascular diseases]. Kardyovask Terap Profyl. 2017;16(5):81-85. [Russian].
  9. Potyazhenko MM, Nevoit AV. Innovatsiyni metodyky ob’yektyvnogo obstezhennya z komp’yuternym testuvannyam v evolyutsiyi registratsyiyi fizychnykh fenomeniv likarem terapevtychnogo profilyu: istoriya, realnist, perspektyvy [Innovative methods of objective examination with computer testing in the evolution of the registration of physical phenomena by physician therapeutic profile: history, reality, prospects]. Medychna informatyka ta inzheneriya. 2018;4:58-65. [Ukrainian]
  10. Potjagenko M, Nevoit A, Sokoluk N, Nevoit M, Ozarchuk L. Bioelectrical impendance method of body composition assessment in algorithm and technologies of healthy lifestyles implementation for prevention and control of Non-Communicable Diseases in the family physician practive. Achiev Clin Exp Med. 2017;2:115-117.
  11. Ballesteros-Pomar M, Calleja-Fernández A, Diez-Rodríguez R, Vidal-Casariego A, Blanco-Suárez M. Comparison of different body composition mesurements in severely obese patients in the clinical setting. Nutr Hosp. 2012;27(5):1626-1630.
  12. Dzau VJ, Braunwald E. Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement. Am Heart J. 1991;121;1244–1263.
  13. BF500 Body Composition Monitor Instruction Manual. Omron Healthcare; 2009. 281-322.
  14. Lavie CJ, De Schutter A, Patel D, Artham SM, Milani RV. Body Composition and Coronary Heart Disease Mortality - An Obesity or a Lean Paradox? Mayo Clin Proc. 2011;86(9):857-864.
  15. De Schutter A, Lavie CJ, Gonzalez J, Milani RV. Body Composition in Coronary Heart Disease: How Does Body Mass Index Correlate With Body Fatness? Ochsner J. 2011;11(3):220-225.
  16. Socha M, Wronecki K, Sobiech KA. Gender and age-dependent differences in body composition changes in response to cardiac rehabilitation exercise training in patients after coronary artery bypass grafting. Ann Agric Environ Med. 2017;24(3):517–521.
  17. Larsson SC, Bäck M, Rees JMB, Mason AM, Burgess S. Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study. Eur Heart J. 2020;41(2):221-226.